INDO US BIOTECH
Back to Income Statement
|
INDO US BIOTECH Last 5 Year Operating Profit History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹19 Cr | ₹11 Cr | ₹9.39 Cr | ₹6.93 Cr | ₹5.51 Cr |
What is the latest Operating Profit of INDO US BIOTECH ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹19 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹9.39 Cr |
| Mar2022 | ₹6.93 Cr |
| Mar2021 | ₹5.51 Cr |
How is Operating Profit of INDO US BIOTECH Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹19 Cr | 75.26 | |
| Mar2024 | ₹11 Cr | 15.03 | |
| Mar2023 | ₹9.39 Cr | 35.52 | |
| Mar2022 | ₹6.93 Cr | 25.70 | |
| Mar2021 | ₹5.51 Cr | - | |
Compare Operating Profit of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹154.9 Cr | -0.7% | -10.6% | -44.8% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹3,585.3 Cr | -2.6% | -9.4% | -38.5% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,317.7 Cr | -7.9% | 9.5% | 11.1% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,309.5 Cr | -4.4% | -1.3% | 11.8% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹939.2 Cr | -0.6% | 2.1% | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹513.5 Cr | -2.3% | 4.2% | 3.1% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -0.7% |
-10.6% |
-44.8% |
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses